434 results
Page 6 of 22
424B5
7ne7j5dmdolu0bsl
18 Jan 19
Prospectus supplement for primary offering
4:59pm
8-K
EX-10.1
f9uv erf572
18 Jan 19
Entry into a Material Definitive Agreement
4:50pm
8-K
EX-99.1
r8es3a7m6 5j307
31 Oct 18
EyePoint Pharmaceuticals Appoints John Landis, Ph.D., M.S., to Board of Directors
4:01pm
8-K/A
EX-99.3
wuawv7r sshei66dp4p
11 Jun 18
Completion of Acquisition or Disposition of Assets
4:54pm